Takeda Pharmaceutical
389 hedge funds and large institutions have $3.64B invested in Takeda Pharmaceutical in 2019 Q1 according to their latest regulatory filings, with 308 funds opening new positions, 62 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
301% more capital invested
Capital invested by funds: $910M → $3.64B (+$2.73B)
4.64% more ownership
Funds ownership: 6.8% → 11.43% (+4.6%)
1% less call options, than puts
Call options by funds: $94.4M | Put options by funds: $95.5M
Holders
389
Holding in Top 10
16
Calls
$94.4M
Puts
$95.5M
Top Buyers
| 1 | +$532M | |
| 2 | +$270M | |
| 3 | +$217M | |
| 4 |
AC
Adelphi Capital
London,
United Kingdom
|
+$189M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$154M |
Top Sellers
| 1 | -$202M | |
| 2 | -$128M | |
| 3 | -$91.6M | |
| 4 |
Goldman Sachs
New York
|
-$47.7M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$23.8M |